C. Ann Merrifield

Insider Reports History

Signature: /s/ Jason Cavalier, Attorney-in-Fact for C. Ann Merrifield
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by C. Ann Merrifield:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Lyra Therapeutics, Inc.	Director	Restricted Stock Units	32K			May 14, 2025	Direct
Lyra Therapeutics, Inc.	Director	Stock Option	30K			Jun 13, 2024	Direct
INVIVO THERAPEUTICS HOLDINGS CORP.	Director	Stock Option (right to buy)	4.2K			Nov 17, 2022	Direct
Flexion Therapeutics Inc	Director	Common Stock	0		$8.50	Nov 19, 2021	Direct
Flexion Therapeutics Inc	Director	Stock option (right to buy)	0			Nov 19, 2021	Direct

Showing 1 to 5 of 5 entries

Insider Reports Filed by C. Ann Merrifield

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
LYRA	Lyra Therapeutics, Inc.	May 14, 2025	1	$0	4	May 16, 2025	Director
LYRA	Lyra Therapeutics, Inc.	Jun 13, 2024	1	$0	4	Jun 14, 2024	Director
LYRA	Lyra Therapeutics, Inc.	Jun 30, 2023	1	$0	4	Jul 5, 2023	Director
NVIV	INVIVO THERAPEUTICS HOLDINGS CORP.	Nov 17, 2022	1	$0	4	Nov 21, 2022	Director
LYRA	Lyra Therapeutics, Inc.	Jun 16, 2022	1	$0	4	Jun 21, 2022	Director
LYRA	Lyra Therapeutics, Inc.	Jun 10, 2022	1	$20.2K	4	Jun 13, 2022	Director
LYRA	Lyra Therapeutics, Inc.	May 13, 2022	2	$18.5K	4	May 17, 2022	Director
FLXN	Flexion Therapeutics Inc	Nov 19, 2021	9	-$162K	4	Nov 19, 2021	Director
FLXN	Flexion Therapeutics Inc	Jun 24, 2021	2	$0	4	Jun 28, 2021	Director
LYRA	Lyra Therapeutics, Inc.	Jun 17, 2021	1	$31.4K	4	Jun 22, 2021	Director
LYRA	Lyra Therapeutics, Inc.	May 26, 2021	1	$0	4	May 28, 2021	Director